Abstract
The protective mechanism of hepatitis B vaccination using surface antigen is the induction of neutralizing antibodies. Hepatitis B surface Antigen (HBsAg) has proven to be well tolerated and effective in many clinical trials 1,2.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
W. Szmuness, C. E. Stevens, E. J. Harley, E. A. Zang, W. R. Oleszko, D. C. William, R. Sadowsky, J. M. Morrison, and A. Kellner, Hepatitis B vaccine. Demonstration of efficacy in a controlled clinical trial in a high-risk population in the united States, N. Engl. J. Med. 303: 833 (1980).
W. Szmuness, C. E. Stevens, E. A. Zang, E. J. Harley, and A. Keffner, A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report, Hepatology 1: 377 (1981)
W. J. McAleer, E. B. Buynac, R. Z. Maigetter, D. E. Wampler, W. J. Miller, and M. R. Hilleman, Human hepatitis B vaccine from recombinant yeast, Nature 307: 178 (1984)
W. Jilg, B. Lorbeer, M. Shmidt, B. Wilske, G Zoulek, and F. Deinhardt, Clinical evaluation of a recombinant hepatitis B vaccine, Lancet ii: 1174 (1984)
T. R. Cupps, J. L. Grein, R. H. Purcell, P. K. Goldsmith, and A. S. Fauci, In vitro antigen-induced antibody response hepatitis B surface antigen in man, J. Clin Invest. 74: 1204 (1984)
G. Fattovich, A. Alberti, C. Crivellaro, P. Pontisso, F. Noventa, and G. Realdi, Cellular immunity to the hepatitis B virion in acute hepatitis type B, Clin. Exp. Immunol. 53: 645 (1983)
U. Hellstrom, S. Sylvan, and P. Lundberg, Regulatory functions of T- and accessory-cells for hepatitis B surface antigen induced specific antibody production and proliferation of human peripheral blood lymphocytes, in vitro, J. Clin. Lab. Immunol. 16: 173 (1985)
M. W. Steward, B. M. Sisley, C. Stanley, S. E. Brown , and C. R. Howard, Immunity to hepatitis B: analysis of antibody and cellular responses in recipients of a plasma-derived vaccine using synthetic peptides mimicking S and pre-S regions, Clin. Exp. Immunol. 71: 19 (1988)
L. G. Filion, R. Saginur, and N. Szczerbak, Humoral and cellular immune responses by normal individuals to hepatitis B surface antigen vaccination, Clin. Exp. Immunol. 71: 405 (1988)
A. Weinberg, and T. C. Merigan, Recombinant interleukin-2 as an adjuvant for vaccined-induced protection, J. Immunol. 140: 294 (1988)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this paper
Cite this paper
Degrassi, A. et al. (1989). Specific Lymphocyte Proliferative Response In Vitro after cDNA HBsAg Immunization. In: Askonas, B.A., Moss, B., Torrigiani, G., Gorini, S. (eds) The Immune Response to Viral Infections. Advances in Experimental Medicine and Biology, vol 257. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5712-4_23
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5712-4_23
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5714-8
Online ISBN: 978-1-4684-5712-4
eBook Packages: Springer Book Archive